Unilens Vision Inc. has announced the launch of the all new C-VUE(R) Advanced(TM) Custom Toric. The  product will be sold directly to independent eye care professionals and features a revolutionary trial program, an advanced hydration material and exceptional deliverability. The C-VUE Advanced Custom Toric is available in new convenient blister packaging with hioxifilcon D. The new product offering and hassle free trial/no returns necessary program will provide independent practitioners with an additional specialty C-VUE contact lens option. This contributes to patient retention and practice profitability.

The U.S. food and Drug Administration has approved safety labeling revisions for Bausch & Lomb, Inc.’s  Retisert (a fluocinolone acetonide intravitreal implant). The new labeling includes warnings based on the now available 3-year clinical reports. Use of the product can cause cataracts which require surgical removal in all phakic eyes within an average 3-year period. About 77% of patients will need drugs to lower intraocular pressure (IOP) within this period, and around 37% of patients may require filtering procedures for controlling elevated IOP.